![Frank Harder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frank Harder
No más puestos en curso
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Knud Carsten Lønfeldt | M | 77 | 6 años | |
Marianne Weile Nonboe | F | 64 | 4 años | |
Thea Wulff Olesen | F | 58 | 8 años | |
Niels Tækker Foged | M | 63 | 6 años | |
Peter Morch Eriksen | M | 64 | 9 años | |
Carl Eistrup | M | - |
Zymenex A/S
![]() Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | - |
Peter Nordkild | M | 69 | 6 años | |
Pia E. Ringholm | F | - |
Zymenex A/S
![]() Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | - |
Fredric D. Price | M | 78 |
Zymenex A/S
![]() Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | 1 años |
Finn Fjorder | M | - | 4 años | |
Laura von Kobyletzki | M | 53 | 1 años | |
Gry Louise Husby Larsen | F | - | 8 años | |
Roar Bjørk Seeger | M | 60 | - | |
Torben Arnth Nielsen | M | 64 | 8 años | |
Mikkel Dührkop | M | - |
Zymenex A/S
![]() Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | - |
Claus Crone Fuglsang | M | 56 | 1 años | |
Thomas Magnussen | M | 71 | 8 años | |
Jan Honoré | M | - |
Zymenex A/S
![]() Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | - |
Otto Rasmussen | M | - | 1 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Dinamarca | 19 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Frank Harder
- Red Personal